Hasselbalch, H., Skov, V., Kjær, L., Larsen, M. K., Knudsen, T. A., Lucijanić, M. & Kušec, R. (2022). Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives. Cancers, 14. (22). doi: 10.3390/cancers14225495
Hasselbalch, Hans, et al. "Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives." Cancers, vol. 14, no. 22, 2022. https://doi.org/10.3390/cancers14225495
Hasselbalch, Hans, Vibe Skov, Lasse Kjær, Morten Kranker Larsen, Trine A. Knudsen, Marko Lucijanić and Rajko Kušec. "Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives." Cancers 14, no. 22 (2022). https://doi.org/10.3390/cancers14225495
Hasselbalch, H., et al. (2022) 'Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives', Cancers, 14(22). doi: 10.3390/cancers14225495
Hasselbalch H, Skov V, Kjær L, Larsen MK, Knudsen TA, Lucijanić M, and sur.. Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives. Cancers [Internet]. 2022 November 09 [cited 2024 August 30];14(22). doi: 10.3390/cancers14225495
H. Hasselbalch, et al., "Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives", Cancers, vol. 14, no. 22, November 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:878867. [Accessed: 30 August 2024]